Scientific, Clinical, and Regulatory Guidance for Investors, Clinics, and Research Organizations
I provide strategic, scientific, and regulatory guidance to investors, clinics, and research teams developing and implementing neuromodulation and mental health technologies. Drawing on experience taking therapies from concept through FDA clearance and commercialization, I help ensure that innovations are grounded in rigorous science, supported by credible clinical evidence, and positioned for real-world success.
Investors & Venture Capital
Scientific, clinical, and regulatory due diligence for neurotechnology and digital health investments.
Services:
Scientific validity assessment (mechanism, plausibility)
Strength of the evidence
Clinical trial design evaluation
Regulatory pathway assessment (FDA likelihood)
Risk identification (scientific + operational)
Commercial pathway assessment
Research Centers & Clinics
Partner with clinics and research centers to build and optimize clinical research programs from trial design and data infrastructure to generating high-quality, publication-ready outcomes.
Services:
Clinical trial design
Clinical assessment training (MADRS, HDRS, CGI, YMRS, MINI etc.)
Real-world data analytics
Registry set-up
Publication writing
Academic collaboration
Design rigorous studies, analyze clinical data, and translate findings into high-impact publications and successfully secure grant funding.
Services:
Manuscript writing
Clinical trial design
Statistical analysis
Grant writing